Goldman Sachs
IRD

Goldman Sachs’s Opus Genetics IRD Stock Holding History

Goldman Sachs’s Portfolio IRD Stock Details IRD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.28M Buy
1,527,229
+1,200,420
+367% +$5.6M ﹤0.01% 3679
2026
Q1 		$1.49M Buy
+326,809
New +$1.13M ﹤0.01% 4789
2021
Q3 		– Sell
-37,315
Closed -$197K – 6566
2021
Q2 		$197K Buy
+37,315
New +$185K ﹤0.01% 5748
2017
Q2 		– Sell
-84
Closed -$21K – 7017
2017
Q1 		$21K Hold
84
– – ﹤0.01% 6503
2016
Q4 		$6K Hold
84
– – ﹤0.01% 6809
2016
Q3 		$9K Sell
84
-17
-17% -$2.05K ﹤0.01% 6886
2016
Q2 		$12K Hold
101
– – ﹤0.01% 6833
2016
Q1 		$16K Buy
101
+17
+20% +$2.83K ﹤0.01% 6802
2015
Q4 		$15K Hold
84
– – ﹤0.01% 6906
2015
Q3 		$21K Sell
84
-40
-32% -$10.9K ﹤0.01% 7023
2015
Q2 		$36K Hold
124
– – ﹤0.01% 6957
2015
Q1 		$44K Sell
124
-130
-51% -$47.2K ﹤0.01% 6731
2014
Q4 		$85K Sell
254
-75
-23% -$25.9K ﹤0.01% 6638
2014
Q3 		$128K Buy
329
+201
+157% +$72.4K ﹤0.01% 6457
2014
Q2 		$53K Sell
128
-61
-32% -$27.7K ﹤0.01% 6746
2014
Q1 		$98K Buy
189
+105
+125% +$56.8K ﹤0.01% 6402
2013
Q4 		$21K Hold
84
– – ﹤0.01% 6535
2013
Q3 		$19K Hold
84
– – ﹤0.01% 6433
2013
Q2 		$18K Buy
+84
New +$14.4K ﹤0.01% 6200

Other funds holding IRD

CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
BCM
BIOS Capital Management Fort Worth, Texas $41.7M AUM 34.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BCM
Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return
TECP
Trails Edge Capital Partners Atlanta, Georgia $630M AUM
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Goldman Sachs's IRD Position: Q2 2026 in Review

Goldman Sachs increased its Opus Genetics (IRD) stake by 367% in Q2 2026, buying an estimated $5.6M and bringing the position to 1,527,229 shares worth $6.28M. The position accounts for ﹤0.01% of the portfolio, ranked #3679.

Goldman Sachs first reported a position in IRD in Q2 2013 and has held it in 19 quarters since. 103 funds tracked by Wall St. Rank hold IRD as of Q2 2026.

  • Goldman Sachs held 1,527,229 shares of Opus Genetics worth $6.28M as of Q2 2026.
  • Goldman Sachs bought 1,200,420 Opus Genetics shares in Q2 2026, an estimated $5.6M.
  • Opus Genetics made up ﹤0.01% of Goldman Sachs's portfolio in Q2 2026, its #3679 holding.
  • Goldman Sachs first reported a position in Opus Genetics in Q2 2013 and has held it in 19 quarters since.
  • 103 funds tracked by Wall St. Rank held Opus Genetics as of Q2 2026.

Based on Goldman Sachs's 13F filing for Q2 2026, filed 14 Aug 2026.